All Stories

  1. Making sense of composite endpoints: efficiency, meaning and clinical relevance in modern cardiovascular trials
  2. Evaluation of Quality of Care in Chagas Disease Cardiomyopathy
  3. Coevolutionary Analysis of Evidence and Recommendations in STEMI Clinical Practice Guidelines: A 33-Year Meta-Research Study of ACC, AHA, and ESC
  4. Economic burden of Chagas disease in Brazil: a nationwide cost-of-illness study
  5. Evolving medical management of erectile dysfunction: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)
  6. Prognostic Value of Resting Heart Rate and Heart Rate Variability in the 12-lead Electrocardiogram: Mortality Data from the CODE Database
  7. Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve replacement: A network meta-analysis
  8. Cardiovascular diseases mortality in Brazilian municipalities: estimates from the Global Burden of Disease study, 2000–2018
  9. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  10. Prevalence of Rheumatic Heart Disease in First-degree Relatives of Index-cases: A Systematic Review and Meta-Analysis
  11. The Impact of the COVID-19 Pandemic on Cardiovascular Diseases Hospitalizations in Brazil
  12. Clinical Outcomes After Valve Intervention in Rheumatic Mitral Valve Disease
  13. Economic Burden of Chagas Disease in Brazil: Evidence from the RAISE Study
  14. Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019
  15. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes
  16. Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis
  17. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  18. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  19. Burden of disease scenarios for 204 countries
  20. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  21. Author Correction: 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease
  22. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  23. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  24. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  25. Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis
  26. Agreement between Handheld and Standard Echocardiography for Diagnosis of Latent Rheumatic Heart Disease in Brazilian Schoolchildren from High-Prevalence Settings (Agreement between Screening and Standard Echo for RHD)
  27. Estatística Cardiovascular – Brasil 2023
  28. Chagas disease deaths detected among garbage codes registered in mortality statistics in Brazil: a study from the buRden of ChAgas dISEase in the contemporary world (RAISE) project
  29. Prevalence of clinical forms of Chagas disease: a systematic review and meta-analysis – data from the RAISE study
  30. Efficacy and safety of catheter ablation for atrial fibrillation in elderly patients: a systematic review and meta-analysis
  31. Combinação de Ferramentas de Telecardiologia para Estratificação de Risco Cardiovascular na Atenção Primária: Dados do Estudo PROVAR+
  32. In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial
  33. Risk Factors for Acute Rheumatic Disease: Exploring Factors at Individual and Collective Levels
  34. The Burden of Chagas Disease in the Contemporary World: The RAISE Study
  35. The Echocardiographic Diagnosis of Rheumatic Heart Disease: A Review of the Performance of the World Heart Federation Criteria 2012–2023
  36. Vagal dysautonomia in patients with Chagas disease and mortality: 14-year results of a population cohort of the elderly
  37. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  38. The economic burden of Chagas disease: A systematic review
  39. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease
  40. Cardiovascular mortality in Brazil during the COVID-19 pandemic: a comparison between underlying and multiple causes of death
  41. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion
  42. Clinical outcomes and progression rate of tricuspid regurgitation in patients with rheumatic mitral valve disease
  43. P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
  44. Oral anticoagulation for atrial fibrillation in rheumatic heart disease
  45. Editorial: Rheumatic fever: 21st century clinical and experimental insights
  46. Early triage echocardiography to predict outcomes in patients admitted with COVID‐19: a multicenter study
  47. Clinical and electrocardiographic outcomes evaluated by telemedicine of outpatients with clinical suspicion of COVID-19 treated with chloroquine compounds in Brazil†
  48. Reasons for disagreement between screening and standard echocardiography in primary care: data from the PROVAR + study
  49. Prevalence of Clinical Forms of Chagas Disease: A Systematic Review and Meta-Analysis – Data from the Raise Study
  50. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  51. Solid Fuel Use and Health in Developing Countries
  52. Predictors of Worsening Erectile Function in Men with Functional Erections Early After Radical Prostatectomy
  53. Predictors of Curvature Improvement in Men with Peyronie's Disease Treated with Intralesional Collagenase Clostridium Histolyticum
  54. Avaliação do Impacto da Implantação de um Sistema de Ambulância Pré-Hospitalar sobre Mortalidade por Infarto Agudo do Miocárdio em um País em Desenvolvimento
  55. Diretrizes, Posicionamentos e Normatizações: Documentos de Auxílio à Prática Médica
  56. Reasons for Disagreement Between Screening and Standard Echocardiography in Primary Care: Data from the PROVAR+ Study
  57. Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial
  58. Prevalence of rheumatic heart disease in adults from the Brazilian Amazon Basin
  59. Grafting Area Reduction in Peyronie’s Disease Surgery: Comparative Assessment Between Double Y Vs iGrafter APP Using 3D-Printed Penile Models
  60. The Burden of Resistant Hypertension Across the World
  61. Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum
  62. Investigation of the Familial Risk of Rheumatic Heart Disease with Systematic Echocardiographic Screening: Data from the PROVAR+ Family Study
  63. Estatística Cardiovascular – Brasil 2021
  64. Carga de Doenças Cardiovasculares Atribuível aos Fatores de Risco nos Países de Língua Portuguesa: Dados do Estudo “Global Burden of Disease 2019”
  65. Burden of Cardiovascular diseases attributable to risk factors in Brazil: data from the "Global Burden of Disease 2019" study
  66. Impact of the COVID-19 pandemic on hospital admissions for cardiovascular diseases in a large Brazilian urban center
  67. Response Letter: Are atypical lymphocytes a new predictive factor in the development of coronavirus disease 2019?
  68. Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies
  69. Cardiac involvement in COVID-19: cause or consequence of severe manifestations?
  70. Tracking development assistance for health and for COVID-19
  71. Mapping Anemia in Women: Global Trends and Inequality
  72. The Global Impact of Rheumatic Heart Disease
  73. Improved standardisation of training needed to achieve the potential of handheld echocardiography
  74. Outcomes of Echocardiography‐Detected Rheumatic Heart Disease: Validating a Simplified Score in Cohorts From Different Countries
  75. Child Mortality Trends and Targets: GBD 2019 Findings
  76. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  77. Diagnosing rheumatic heart disease: where are we now and what are the challenges?
  78. Text Messages to Promote Secondary Prevention after Acute Coronary Syndrome (IMPACS trial)
  79. Sucessos e Desafios no Enfrentamento das Doenças Cardiovasculares no Brasil: Viver Mais e Melhor
  80. Towards automatic diagnosis of rheumatic heart disease on echocardiographic exams through video-based deep learning
  81. Regressão do Supradesnivelamento do Segmento ST como Preditor de Reperfusão no Infarto Agudo do Miocárdio: Uma Incógnita Persistente
  82. Impact of COVID-19 Pandemic on the Sexual Function of Health Professionals From an Epicenter in Brazil
  83. Racial disparity in excess mortality in Brazil during COVID-19 times
  84. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  85. Echocardiography at Bedside For Predicting Mortality of COVID-19 Patients Beyond Clinical Data – Data From the PROVAR-COVID Study
  86. Equidade entre Sexos no Acesso à Reperfusão no Infarto Agudo do Miocárdio: Um Longo Caminho a ser Percorrido
  87. Cytokine gene functional polymorphisms and phenotypic expression as predictors of evolution from latent to clinical rheumatic heart disease
  88. The psychiatric impact of COVID-19 pandemic on sexual health
  89. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
  90. Bedside echocardiography to predict mortality of COVID-19 patients beyond clinical data: Data from the PROVAR-COVID study
  91. Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System
  92. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  93. Impact of a large-scale telemedicine network on emergency visits and hospital admissions during the coronavirus disease 2019 pandemic in Brazil: Data from the UNIMED-BH system
  94. Echocardiographic screening of pregnant women by non-physicians with remote interpretation in primary care
  95. Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities
  96. Impact of incorporating echocardiographic screening into a clinical prediction model to optimise utilisation of echocardiography in primary care
  97. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
  98. Estatística Cardiovascular – Brasil 2020
  99. Federated and secure cloud services for building medical image classifiers on an intercontinental infrastructure
  100. Physical inactivity as a risk factor for all-cause mortality in Brazil (1990–2017)
  101. The burden of diabetes and hyperglycemia in Brazil: a global burden of disease study 2017
  102. The burden of disease among Brazilian older adults and the challenge for health policies: results of the Global Burden of Disease Study 2017
  103. Trends in mortality due to non-communicable diseases in the Brazilian adult population: national and subnational estimates and projections for 2030
  104. Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the “Global Burden of Disease 2017” (GBD 2017) study
  105. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study
  106. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
  107. A Critical Analysis of Methodology Pitfalls in Duplex Doppler Ultrasound in the Evaluation of Patients with Erectile Dysfunction: Technical and Interpretation Deficiencies
  108. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  109. Excess of Cardiovascular Deaths During the COVID-19 Pandemic in Brazilian Capital Cities
  110. Evaluating the Impact of Penile Girth Discrepancy on Patient Bother in Men with Peyronie's Disease: An Observational Study
  111. Trends in prevalence, mortality and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the “Global Burden of Disease 2017” (GBD2017) study
  112. Validation of a simplified score for predicting latent rheumatic heart disease progression using a prospective cohort of Brazilian schoolchildren
  113. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
  114. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  115. Aterosclerose e Inflamação: Ainda Muito Caminho a Percorrer
  116. Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
  117. Atrial fibrillation detection with a portable device during cardiovascular screening in primary care
  118. Re: Development of Nomograms to Predict the Recovery of Erectile Function following Radical Prostatectomy
  119. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017
  120. Morbidity and mortality from road injuries: results from the Global Burden of Disease Study 2017
  121. Health Education about Rheumatic Heart Disease: A Community-Based Cluster Randomized Trial
  122. Tratamento da Estenose Aórtica do Idoso no Brasil: Até Quando Podemos Esperar?
  123. Audiovisual Sexual Stimulation Improves Diagnostic Accuracy of Penile Doppler Ultrasound in Patients With Erectile Dysfunction
  124. Rheumatic heart disease and socioeconomic development
  125. Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy
  126. Percutaneous closure of ostium secundum atrial septal defect using left internal jugular vein access in a child with situs inversus and absence of inferior caval vein
  127. Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
  128. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry
  129. Department of Error
  130. Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS)
  131. Neuropsychiatric Syndromes in Childhood-Onset Systemic Lupus Erythematosus
  132. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  133. Cardiac Involvement by Yellow Fever(from the PROVAR+ Study)
  134. Simplified Echocardiography Screening Criteria for Diagnosing and Predicting Progression of Latent Rheumatic Heart Disease
  135. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  136. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
  137. Fighting Rheumatic Heart Disease: What are the next moves?
  138. Guidelines os the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019
  139. Medical Imaging Processing Architecture on ATMOSPHERE Federated Platform
  140. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  141. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  142. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  143. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  144. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  145. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  146. Department of Error
  147. Digoxin for rheumatic heart disease: a cautious future for a drug from the past?
  148. Implementing myocardial infarction systems of care in low/middle-income countries
  149. Impact of left atrial compliance improvement on functional status after percutaneous mitral valvuloplasty
  150. Integration of echocardiographic screening by non-physicians with remote reading in primary care
  151. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  152. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome
  153. Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial
  154. Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
  155. Value of the Electrocardiographic (P Wave, T Wave, QRS) Axis as a Predictor of Mortality in 14 Years in a Population With a High Prevalence of Chagas Disease from the Bambuí Cohort Study of Aging
  156. Cardiovascular Disease Epidemiology in Portuguese-Speaking Countries: data from the Global Burden of Disease, 1990 to 2016
  157. Prevention and control of rheumatic heart disease: Overcoming core challenges in resource-poor environments
  158. A focussed single-view hand-held echocardiography protocol for the detection of rheumatic heart disease – CORRIGENDUM
  159. A focussed single-view hand-held echocardiography protocol for the detection of rheumatic heart disease
  160. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  161. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  162. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015
  163. Net atrioventricular compliance is an independent predictor of cardiovascular death in mitral stenosis
  164. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  165. Factors associated with compliance to AHA/ACC performance measures in a myocardial infarction system of care in Brazil
  166. Variações e diferenciais da mortalidade por doença cardiovascular no Brasil e em seus estados, em 1990 e 2015: estimativas do Estudo Carga Global de Doença
  167. Challenges for the Implementation of the First Large-Scale Rheumatic Heart Disease Screening Program in Brazil: The PROVAR Study Experience
  168. Telehealth solutions to enable global collaboration in rheumatic heart disease screening
  169. Echocardiographic prevalence of rheumatic heart disease in Brazilian schoolchildren: Data from the PROVAR study
  170. Efficacy of a Standardized Computer-Based Training Curriculum to Teach Echocardiographic Identification of Rheumatic Heart Disease to Nonexpert Users
  171. Rheumatic heart disease echocardiographic screening: approaching practical and affordable solutions
  172. Trends in Procedure Type, Morbidity and In-Hospital Outcomes of Patients with Peripheral Artery Disease: Data from the Brazilian Public Health System
  173. Update on percutaneous mitral commissurotomy
  174. Almanac 2014: Global Health and Cardiovascular Disease
  175. In-hospital mortality risk prediction after percutaneous coronary interventions: Validating and updating the toronto score in Brazil
  176. Effect of pacemaker site on B-type natriuretic peptide levels and left ventricular function in a population with high prevalence of Chagas disease
  177. Meta-Analysis of Deferral Versus Performance of Coronary Intervention Based on Coronary Pressure–Derived Fractional Flow Reserve
  178. Heart Rate Variability and Chagas Heart Disease
  179. Cardiac Medications Can Influence the Exercise Prescription in Chagas Heart Disease
  180. Global health and cardiovascular disease
  181. Factors associated with progression of coronary artery disease measured by intravascular ultrasound: Systematic review and meta-analysis
  182. Diagnostic accuracy of intravascular ultrasound‐derived minimal lumen area compared with fractional flow reserve—Meta‐analysis: Pooled accuracy of IVUS luminal area versus FFR
  183. Effects of Exercise Training on Heart Rate Variability in Chagas Heart Disease
  184. Improvement of the functional capacity is associated with BDNF and autonomic modulation in Chagas disease
  185. The Impact of Right Ventricular Stroke Work on B‐Type Natriuretic Peptide Levels in Patients With Mitral Stenosis Undergoing Percutaneous Mitral Valvuloplasty
  186. Implementation of the Myocardial Infarction System of Care in City of Belo Horizonte, Brazil
  187. Rest left ventricular function and contractile reserve by dobutamine stress echocardiography in peripartum cardiomyopathy
  188. The prognostic significance of electrocardiographic changes in Chagas disease
  189. Complete Atrioventricular Block As the First Manifestation of Noncompaction of the Ventricular Myocardium
  190. Endocardite infecciosa em câmaras direitas: discrepância entre evolução clínica e ecocardiográfica: relato de caso
  191. Challenges in consenting subjects for studies with brain stimulation: feasibility of multimedia video use during the informed consent process
  192. Ranolazine Exerts Potent Effects on Atrial Electrical Properties and Abbreviates Atrial Fibrillation Duration in the Intact Porcine Heart
  193. Noninvasive assessment of endothelial function and ST segment changes during exercise testing in coronary artery disease
  194. Can we measure the ankle-brachial index using only a stethoscope? A pilot study
  195. Espessamento médio-intimal da carótida e função endotelial na doença arterial coronariana